Provided by Tiger Fintech (Singapore) Pte. Ltd.

Soleno Therapeutics

74.86
-0.4100-0.54%
Pre-market: 72.50-2.3600-3.15%08:00 EDT
Volume:701.82K
Turnover:52.52M
Market Cap:3.74B
PE:-17.10
High:75.70
Open:74.23
Low:73.08
Close:75.27
Loading ...
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 21, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report